Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Novo Nordisk is planning staff reductions of approximately 250 employees in the US as part of a reorganization resulting from an assessment of resource needs against its business priorities. Last month (September 2018), the company announced staff...

The European Medicines Agency (EMA) has revised the number of centrally authorized medicines (CAPs) for which there are concerns of supply disruptions due to the UK’s exit from the European Union (EU) (i.e., Brexit) from 108 to 39. The revision...

Dr. Reddy’s Laboratories, a Hyderabad, India-headquartered pharmaceutical company, has sold its antibiotic manufacturing facility and related assets in Bristol, Tennessee to Neopharma, a pharmaceutical company headquartered in Abu Dhabi, United...

Takeda plans to close its US headquarters in Deerfield, Illinois and move its functions to the Boston area. The move follows Takeda’s proposed $62-billion acquisition of Shire, announced in May 2018, which is scheduled to be completed in the first...

Merck & Co. announced that Kenneth C. Frazier, Chairman and Chief Executive Officer, has agreed to remain in his position beyond December 2019, when he turns 65. The company’s Board of Directors rescinded its policy subjecting the company’s CEO...

Alexion Pharmaceuticals, a Boston-headquartered pharmaceutical company, has agreed to acquire Syntimmune, a Boston, Massachusetts-based clinical-stage biopharmaceutical company developing antibody therapeutics targeting the neonatal Fc receptor...